The history of hormone replacement therapy started in the 1960s, vastly increasing in popularity in the 1990s, then sought a decline after 2002 due to a study by the Women's Health Initiative (WIH). The study published the potential risks of estrogen and progestin therapy in increasing women’s risk of heart disease and breast cancer. After this was publicized in the media, many women shied away from hormonal replacement treatment.
However, evidence since then suggests these results are not as alarming as they originally appeared. We are now seeing a gradual increase in the use of hormone replacement therapy, especially in younger women with troublesome symptoms.
Experts argue that for women under the age of 60 with perimenopausal and postmenopausal symptoms, the benefits may outweigh the risks. Understanding the benefits, risks, and timeline of estradiol patches, a form of hormone replacement therapy can help set realistic expectations and ensure effective management of symptoms.
[signup]
What is Estradiol and How Do Estradiol Patches Work?
Hormonal replacement therapy, with the administration of estrogen, progesterone, and/or testosterone, can alleviate symptoms such as hot flashes and night sweats, vaginal symptoms, sleep disturbances, and mood changes, and may even help prevent long-term health issues such as osteoporosis and support cardiovascular health.
Estradiol, a form of estrogen, is a critical hormone in the function and development of female and male reproductive systems. It regulates the menstrual cycle by promoting the growth of the uterine lining, triggers luteinizing hormone for ovulation, and supports the fetus throughout pregnancy.
Estrogen regulates the distribution of body fat in females and is essential for breast development. It also has neuroprotective properties, including regulating mood and cognitive function.
An important function of estrogen is its influence on the acid pH in the vaginal canal, with normal ranges between 4.5-6.0. Estrogen decreases vaginal pH. In menopause and postmenopause, with this decrease of estrogen, there is an alkalinization of the vaginal canal to about 6.5-7.0. A vaginal pH of greater than 6.5 correlates with an increased risk of vaginal infections and symptoms such as dyspareunia (pain during sex), urinary tract infections, vaginal itching, and vaginal dryness.
Postmenopausal women are at a higher risk of osteoporosis or when bones become weak and brittle. This is due to the estrogen decline in menopause. Estradiol helps maintain bone density by inhibiting bone breakdown.
Estradiol has a vasodilating effect, which helps maintain healthy blood pressure levels and has an impact on maintaining healthy cholesterol levels, reducing cardiovascular risk.
Estradiol transdermal patches deliver hormones transdermally (through the skin). When the patch is applied, estradiol diffuses from the patch into the epidermis (the upper skin layer), then makes its way into the deeper dermis. From the dermis, estradiol is absorbed into the bloodstream through the capillaries, providing its effects throughout the body.
With this absorption type, estradiol bypasses the liver initially, leading to higher bioavailability and potentially lower doses needed for an optimal effect. It also avoids the gastrointestinal tract, reducing the risk of gastrointestinal side effects compared to oral forms of estrogen.
Patches are typically changed once or twice a week, which may be more convenient for some than taking an oral formulation. They provide a more continuous release of estradiol, leading to more stable blood hormone levels.
There is evidence that transdermal estradiol may carry a lower risk of thromboembolism or blood clots than oral forms.
Expected Timeline for Estradiol Patches to Start Working
Transdermal estrogen patches can cause an improvement in symptoms within two weeks. The time it takes for symptom relief can vary amongst patients and symptoms. It normally takes 11-13 hours for the body to metabolize through a patch. However, there may be variations based on body weight.
Data from several studies suggested that estrogen replacement therapy had antidepressant effects or that it enhanced the effects of antidepressant treatment in perimenopausal women.
Mood symptoms may take up to a few months for symptom relief. Research has shown that the use of estradiol can decrease stress by reducing the release of cortisol in response to a physical stressor. Mood and sleep improvements may take a few weeks to months.
A study conducted over 12 months found vasomotor symptoms of menopause (hot flashes, night sweats, heart palpitations, changes in blood pressure) improved by 73% in perimenopausal women with the use of transdermal estradiol.
Some people may experience skin irritation at the site of transdermal patch application. Rotating location sites is recommended to reduce this risk. For optimal application, it’s best to avoid lotion or oils in the area where a patch will be applied to avoid adhesion issues.
Within the first week of use, patients may experience symptoms contributing to the new influx of estrogen, such as headaches or breast tenderness, as well as being more emotional or irritable. If a patient still has a menstrual cycle, periods may be lighter, heavier, or irregular as the body adjusts.
Factors Influencing the Effectiveness of Estradiol Patches
Absorption rates can vary between individuals and between different estrogen patches. Variations in estrogen patches include the type of estrogen used and the design. A person’s skin quality, age, body weight, and metabolism are all factors that could affect absorption rates.
It’s important to follow estrogen patch application recommendations, such as rotating patch sights, to maximize its effectiveness and maintain skin health. The skin should be clean and dry, and the patch should be placed in an area with less oil production and hair growth. Patch replacements should be performed as recommended, as not following a schedule can disrupt hormone levels.
Examples of FDA-Approved Estradiol Transdermal Patches
- Climara 0.025, 0.0375, 0.05, 0.075, 0.1 mg/day applied once weekly
- Esclim 0.025, 0.0375, 0.075, 0.1 mg/day applied twice weekly
- Fempatch 0.025 mg/day applied once weekly
- Menostar 0.014 mg/day applied once weekly
- Vivelle 0.025, 0.0375, 0.05, 0.075, 0.1 mg/day applied twice weekly
- Vivelle Dot 0.025, 0.0375, 0.05, 0.075, 0.1 mg/day applied twice weekly
Individuals must seek guidance in hormone replacement therapy from trained and experienced healthcare professionals. These professionals may make adjustments necessary to optimize effectiveness based on each individual’s personal responses.
Monitoring and Evaluating Effectiveness
Patients keeping a symptoms diary can help provide healthcare hormone experts with valuable information and a clearer picture of their symptoms, response, and overall journey with estrogen patches and hormone replacement therapy.
Key symptoms important to record include:
- Sleep quality
- Stress levels based on a 1-10 scale
- Mood, anxiety, depression, and irritability
- Hot flashes, night sweats
- Vaginal dryness, itching, irritation
- Pain with sexual intercourse
- Hair texture changes, hair growth or loss
- Joint pain and swelling
- Low libido
- Brain fog, concentration
Regular check-ups with health care professionals are crucial in optimizing hormone levels, evaluating effectiveness, monitoring risk and long-term health, and managing side effects. Hormone replacement therapy must be tailored to every individual's needs, medical history, and symptoms. A risk versus benefit analysis is vital to be performed on all patients.
Other Lab Tests and Biomarkers to Test
Monitoring blood hormone levels before and throughout treatment is essential to obtain baseline values, along with monitoring hormone replacement progress. Balancing the body’s hormonal balance is an intricate process that will differ based on every patient’s specific needs.
Blood hormone levels to consider ordering in evaluating patients for hormone replacement therapy include:
- Estradiol
- Testosterone, Total and Free
- DHEA
- Follicular Stimulating Hormone (FSH)
- Luteinizing Hormone (LH)
- Progesterone
- Sex Hormone-Binding Globulin (SHBG)
- Thyroid-Stimulating Hormone (TSH)
- Free Triiodothyronine (T3)
- Free Thyroxine (T4)
- Thyroid Peroxidase Antibodies (TPO Abs)
- Thyroglobulin Antibodies (TG Abs)
Monitoring bone health is especially important in postmenopausal women due to the elevated risk of developing osteoporosis and related complications such as bone fractures. Early detection of risks can be prevented through the use of bone density scans or DEXA scans.
Current recommendations of DEXA scans include screening every woman over the age of 65. All postmenopausal women over the age of 50 should be assessed for osteoporosis risk, with risk factors such as a family history of osteoporosis, history of previous fractures, long-term steroid use, or smoking. Women with osteoporosis should be monitored more closely, with scanning every 1-2 years.
As discussed previously in this article, the decrease in estrogen in menopausal and postmenopausal patients can increase the risk of cardiovascular disease. Monitoring lipid profiles to assess these patients' cardiovascular health is essential.
Blood glucose, fasting insulin, and hemoglobin A1c levels should also be considered in this patient population, as a woman's metabolism undergoes several changes in menopause. Menopause can lead to changes in how the body processes glucose, potentially increasing insulin resistance and increasing the risk of type 2 diabetes.
[signup]
Key Takeaways
- The expected timeline of symptom relief with estradiol patches will vary depending on every individual and the symptoms they are experiencing. Symptom relief can first be experienced within a couple of weeks, with hormone optimization taking up to 6 months.
- Hormone replacement therapy is extremely personalized, with varying dosages and formulations available. Patients can optimize effectiveness by following recommended protocols and application processes.
- Regular monitoring of hormone replacement is crucial to evaluate effectiveness and safety to reach health optimization and disease prevention. Patients are encouraged to consult with specialized hormone healthcare providers for tailored treatment plans to their personal needs and goals, which may also include lifestyle changes.
%201.svg){kind=logo}
